(NASDAQ: NRXP) has re-filed its Abbreviated New Drug Application (ANDA) for KETAFREE, a preservative-free IV ketamine treatment, moving closer to expanding options for patients in need
After reconstitution, the bacteriostatic water preservative protects the solution from bacterial contamination across multiple draws the primary advantage over plain sterile water
High-Performance Liquid Chromatography confirms purity 98%
Acknowledgements Members of the General Practice Research Group who conducted the study include: AD Bell, J Cha, GM Fullerton, DJ Harterre, D Henry, V Martinho, BA Melbourne, MJ Mills, JL Nichols, JA Opie, I Siegel, DR Spink, K-W Tan, RK Tee, RJ Whatley, W Winzer, PA Zuliani
Prescriptions provided by U.S
812 Weeks: Enhanced tissue integrity, reduced scarring, and improved endurance